Abstract
IL-13 is strongly implicated in the development of asthma and chronic obstructive polymonary disease (COPD). We previously identified an IL-13 promoter polymorphism (−1055 C to T) that is associated with allergic asthma. We now report an increased frequency of the −1055 T allele in COPD patients compared to healthy controls (P=0.002) and compared to a second control group consisting of smoking individuals with normal lung function (P=0.01). A closely linked IL-13 exon polymorphism is present at normal allelic frequencies (P=0.3 and 0.4, respectively). In addition, we observed a normal distribution of two IL-4 polymorphisms at positions −590 and +33 (P=0.2 and 0.9, respectively). These results could implicate a functional role for the IL-13 promoter polymorphism in the enhanced risk to develop COPD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barnes PJ . Chronic obstructive pulmonary disease N Engl J Med 2000 343: 269–280
Balzano G, Stefanelli F, Iorio C et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function Am J Respir Crit Care Med 1999 160: 1486–1492
O'Byrne PM, Postma DS . The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group Am J Respir Crit Care Med 1999 159: 41-S63
Sluiter HJ, Koeter GH, de, Monchy JG et al. The Dutch hypothesis (chronic non-specific lung disease) revisited Eur Respir J 1991 4: 479–489
Tashkin DP, Altose MD, Connett JE et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group Am J Respir Crit Care Med 1996 153: 1802–1811
Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP . Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study Lancet 2000 356: 1313–1317
Hospers JJ, Schouten JP, Weiss ST, Rijcken B, Postma DS . Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample Am J Respir Crit Care Med 1999 160: 1869–1874
Postma DS, Bleecker ER, Amelung PJ et al. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy N Engl J Med 1995 333: 894–900
Doull IJM, Lawrence S, Watson M et al. Allelic association of gene markers on chromosome 5q and 11q with atopy and bronchial hyperresponsiveness Am J Respir Crit Care Med 1996 153: 1280–1284
Marsh DG, Neely JD, Breazeale DR et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations Science 1994 264: 1152–1156
A genome-wide search for asthma susceptibility loci in ethnically diverse populations: The Collaborative Study on the Genetics of Asthma (CSGA) Nat Genet 1997 15: 389–392
Hilton DJ, Zhang J, Metcalf D et al. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor Proc Nat Acad Sci 1996 93: 497–501
Grunig W, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma Science 1998 282: 2261–2263
Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma Science 1998 282: 2258–2261
Zheng T, Zhu Z, Wang Z et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema J Clin Invest 2000 106: 1081–1093
van der Pouw Kraan TC, van Veen A, Boeije LC et al. An IL-13 promoter polymorphism associated with increased risk of allergic asthma Genes Immun 1999 1: 61–65
van der Pouw Kraan TC, Aarden LA, Verweij K et al. Polymorphism in the IL-13 promoter Science 1999 286: 1647b
Graves PE, Kabesch M, Halonen M et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children J Allergy Clin Immunol 2000 105: 506–513
Liu X, Nickel R, Beyer K et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS- 90) J Allergy Clin Immunol 2000 106: 167–170
Heinzmann A, Mao XQ, Akaiwa M et al. Genetic variants of IL-13 signalling and human asthma and atopy Hum Mol Genet 2000 9: 549–559
Rosenwasser LJ, Klemm DJ, Dresback JK et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy Clin Exp Allergy 1995 25: (Suppl. 2) 74–78
Suzuki I, Yamaguchi E, Hizawa N, Itoh A, Kawakami Y . A new polymorphism in the 5' flanking region of the human interleukin (IL)-4 gene Immunogenetics 1999 49: 738–739
Suzuki I, Hizawa N, Yamaguchi E, Kawakami Y . Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels Clin Exp Allergy 2000 30: 1746–1749
American Thoracic Society. Medical section of the American Lung Association. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 1987 136: 225–244
Cohn L, Homer RJ, MacLeod H et al. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils J Immunol 1999 162: 6178–6183
McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN . A distinct role for interleukin-13 in Th2-cell-mediated immune responses Curr Biol 1998 8: 339–342
Vestbo J, Prescott E, Lange P . Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group Am J Respir Crit Care Med 1996 153: 1530–1535
Prescott E, Lange P, Vestbo J . Chronic mucus hypersecretion in COPD and death from pulmonary infection Eur Respir J 1995 8: 1333–1338
Acknowledgements
This study was financially supported by the Dutch League against Rheumatism and GlaxoSmithKline.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van der Pouw Kraan, T., Küçükaycan, M., Bakker, A. et al. Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 3, 436–439 (2002). https://doi.org/10.1038/sj.gene.6363896
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363896